Navigation Links
Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-GSK3 Rx and Earns $3 Million Milestone Payment From GSK
Date:11/26/2013

ual report on Form 10-K for the year ended December 31, 2012, and its most recent quarterly report on Form 10-Q, which are on file with the SEC. Copies of these and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries.

Isis Pharmaceuticals® is a registered trademark of Isis Pharmaceuticals, Inc.  Regulus Therapeutics™ is a trademark of Regulus Therapeutics Inc.  KYNAMRO™ is a trademark of Genzyme Corporation.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Isis Pharmaceuticals to Present at the 2013 Deutsche Bank BioFEST
2. Sitari Pharmaceuticals, First Company Launched Through Avalon Ventures-GlaxoSmithKline Collaboration, Raises up to $10 Million Series A Financing and R&D Support
3. DelMar Pharmaceuticals Presents Interim Phase 1/2 Clinical Data for VAL-083 in Glioblastoma at Society for Neuro-Oncology Annual Meeting
4. Isis Pharmaceuticals to Investigate a Higher Dose of ISIS-SMN Rx in Children with Spinal Muscular Atrophy
5. Alexza Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
6. Absorption Pharmaceuticals Expands Sales and Service Team to Answer Physicians Growing Demand for Promescent
7. Actinium Pharmaceuticals To Present At The LD Micro Conference
8. Acquisitions, Conference Participations, Court Rulings, and Product Deliveries - Research Report on Zoetis, Aegerion Pharmaceuticals, Edwards, Community Health Systems, and Air Methods
9. Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
10. Immune Pharmaceuticals Reports Third Quarter 2013 Financial Results
11. Viteava Pharmaceuticals Executes Worldwide Exclusive License
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... HOUSTON , July 28, 2014  Houston ... announces that he offers orthodontic treatment with Invisalign. ... area patients can have their teeth straightened without ... same long-term benefits associated with other types of ... enjoy natural looks in addition to better support ...
(Date:7/28/2014)... ResMed (NYSE: RMD ), innovatore e pioniere ... respiratori del sonno (SDB) e altre patologie croniche del ... il produttore Taiwanese di dispositivi medicali, APEX Medical Corp. ... in testa, che violano i brevetti, utilizzate con l,APEX ... Corte Regionale Distrettuale di Monaco , ...
(Date:7/28/2014)... England , July 28, 2014 /PRNewswire/ ... dass Albion Ventures 2,5 Millionen £ investiert ... in der Konsumgüter-, Gesundheits-, Pharma- und Logistikbranche ... Ventures.      (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ... 18 Monaten hat OmPrompt sein beschleunigtes Wachstum ...
Breaking Medicine Technology:Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2
... July 7, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... subsidiary, Watson Laboratories, Inc., filed an Abbreviated New ... Drug Administration (FDA) seeking approval to market lisdexamfetamine ... generic version of Shire LLC,s Vyvanse®. Vyvanse® is ...
... 7, 2011 The U.S. Food and Drug Administration ... exercise enforcement discretion with respect to the premarket notification ... radiology devices with well-established safety and effectiveness profiles. ... The draft guidance lists 30 different device types, including ...
Cached Medicine Technology:Watson Confirms Vyvanse® Patent Challenge 2FDA Proposes New Policy for Some Diagnostic and Radiology Devices 2
(Date:7/28/2014)... are on the cusp of revolutionizing health care, armed ... from cardiac measurements to sonograms. , While tremendous potential ... costs, several health law experts say in a just-published ... that more oversight is needed by the U.S. Food ... safety. Out of some 100,000 mHealth apps on the ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 According ... Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition ... ALD), Product (Power, Opto-electronic), Application, and Geography-2013-2020", published ... at a CAGR of 12.63% from 2014 to ... Browse 121 market data tables and 88 figures ...
(Date:7/28/2014)... July 28, 2014 According to a ... Solution Software Market- Global Industry Analysis, Size, Share, Growth, ... device market was valued at USD 3,005 million in ... of 13.8% from 2014 to 2020, to reach an ... Globally, the e-clinical solution software market is witnessing significant ...
(Date:7/28/2014)... in Taiwan has developed a new optical technology that ... diabetes sooner, when it is more easily treated. If ... it may pave the way for the early detection ... autonomic neuropathy, which is common among people with both ... affects the autonomic nerves controlling vital organs like the ...
(Date:7/28/2014)... Axiom EPM , a leading ... performance management software for enterprises, today announced that it ... that surpassed its record Q1 results, and adding more ... this growth to increased demand for its comprehensive suite ... addition of incremental solutions for existing customers. New clients ...
Breaking Medicine News(10 mins):Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Health News:Wearable device for the early detection of common diabetes-related neurological condition 2Health News:Axiom EPM Announces Record Second Quarter of 2014 2
... seems to be reaching epidemic proportions, forcing changes in ... are now revamping their fleet of ambulances to cope ... ,Super-sized vehicles have been introduced and new air ... ambulances will now be equipped with heavy-duty stretchers, capable ...
... has approved four new drugs manufactured by the Macleods of ... of the four would be used against some strains of ... these four medicines will reinforce efforts to scale up access ... a statement. ,The medicines are the first TB ...
... While it is well known that genetics and family history ... lifestyle choices which include diet//, exercise and environment, do play ... session of the American College of Cardiology looked at many ... person’s chances of being diagnosed with heart disease. ...
... claim that they can efficiently seek out and kill ... very similar to the Nature's way of distinguishing one ... tumor targeting strategy, presented today (March 25) at the ... harnesses one of the body's natural antibodies and immune ...
... has sought for more organ donations so as to meet ... According to him there is a big gap between the ... ,Statistics reveal that 1.5 million patients need organ transplants each ... In China organs are donated by people after signing voluntary ...
... all mental health units in England and Wales revealed ... This is much against the government’s claim that this ... ,The healthcare commission reports that 55% of in-patients are ... opposite sex. This practice has resulted in an increase ...
Cached Medicine News:Health News:Indian Pharma Authorized to Market New Anti-TB Drugs 2Health News:Role of Lifestyle Choices in Heart Risks 2Health News:Role of Lifestyle Choices in Heart Risks 3Health News:Tumors Targeted Naturally 2Health News:Tumors Targeted Naturally 3
... operating and recovery room, ,The Cardiocap ... haemodynamic and airway gas monitoring for induction ... units. The Cardiocap II is available in ... haemodynamic measurements. Two of the models include ...
Precordial Chestpieces are manufactured from chrome plated brass. Provides a hollow design with deep sound chambers for optimum acoustics....
For accurately monitoring heart and breath sounds....
For accurately monitoring core temperature and heart and breath sounds....
Medicine Products: